The Interplay Between the Immune Cells and Microbial Dysbiosis in the Development of Endometriotic Lesions: Implications for Revisiting Hormonal and Surgical Treatments
Year: 2026
Type: article
Abstract: Endometriosis is a chronic, estrogen-dependent, inflammatory and fibrotic disease characterized by endometrial-like tissue outside the uterine cavity. Although retrograde menstruation explains the presence of endometrial fragments in the peritoneal cavity, it does not explain why only a subset of women develop persistent lesions, chronic pain or infertility. Increasing evidence indicates that endometriosis emerges from a permissive immunological and microbial ecosystem in which ectopic cells evade clearance, induce angiogenesis and neurogenesis, remodel extracellular matrix and sustain chronic inflammation. Immune abnormalities include macrophage expansion and M2-like polarization, impaired natural killer cell cytotoxicity, tolerogenic dendritic cells, altered neutrophil and mast-cell activity, Th17/Treg imbalance, exhausted cytotoxic T cells, B-cell activation and autoantibody production. In parallel, microbial dysbiosis in the gut, vagina, cervix, endometrium and peritoneal cavity may influence lesion biology through lipopolysaccharide/TLR4 activation, increased intestinal permeability, estrogen recycling by the estrobolome, short-chain fatty acid depletion, altered bile acid and tryptophan metabolism, and modulation of macrophage, NK-cell and T-cell phenotypes. This review explored the bidirectional immune-microbiota interactions that may drive the implantation, survival and progression of endometriotic lesions. We propose an “immune-microbial endocrine loop” in which dysbiosis amplifies inflammation and estrogenic signaling, while endometriotic lesions reshape local and systemic microbial niches. This paradigm has implications for current treatments. Hormonal suppression reduces estrogenic stimulation and symptoms but may not fully correct immune-microbial drivers. Surgery removes visible lesions but cannot necessarily reset the inflammatory microbiome or prevent recurrence. Revisiting hormonal and surgical strategies through an immune-microbial lens supports adjunctive approaches such as perioperative microbiome profiling, anti inflammatory nutrition, probiotics, postbiotics, selective antibiotics, estrobolome modulation, macrophage/ NK-cell-targeted therapy and personalized postoperative suppression. Robust longitudinal human studies and mechanism-based trials are required before microbiome-directed interventions can be routinely integrated into care.
Source: SVOA Medical Research
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Keywords: endometriosis, endometriotic lesions, dysbiosis, gut microbiota, vaginal microbiota, estrogen signaling, estrobolome, short-chain fatty acids, bile acid metabolism, tryptophan metabolism, intestinal permeability, macrophage polarization, M2 macrophages, natural killer cells, Th17/Treg imbalance, chronic inflammation, surgical treatment, endometriosis recurrence, probiotics, postbiotics, macrophage-targeted therapy
Open Access status: bronze
OpenAlex ID: W7226158374
